Growth Metrics

Dynavax Technologies (DVAX) Common Equity (2016 - 2025)

Historic Common Equity for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $534.1 million.

  • Dynavax Technologies' Common Equity fell 2161.48% to $534.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $534.1 million, marking a year-over-year decrease of 2161.48%. This contributed to the annual value of $596.8 million for FY2024, which is 406.27% down from last year.
  • As of Q3 2025, Dynavax Technologies' Common Equity stood at $534.1 million, which was down 2161.48% from $494.2 million recorded in Q2 2025.
  • In the past 5 years, Dynavax Technologies' Common Equity registered a high of $681.4 million during Q3 2024, and its lowest value of $67.6 million during Q3 2021.
  • Over the past 5 years, Dynavax Technologies' median Common Equity value was $534.1 million (recorded in 2025), while the average stood at $459.6 million.
  • As far as peak fluctuations go, Dynavax Technologies' Common Equity surged by 74372.46% in 2021, and later tumbled by 2312.94% in 2025.
  • Over the past 5 years, Dynavax Technologies' Common Equity (Quarter) stood at $222.4 million in 2021, then skyrocketed by 161.28% to $581.0 million in 2022, then rose by 7.07% to $622.1 million in 2023, then dropped by 4.06% to $596.8 million in 2024, then fell by 10.5% to $534.1 million in 2025.
  • Its last three reported values are $534.1 million in Q3 2025, $494.2 million for Q2 2025, and $530.9 million during Q1 2025.